<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:29:08" record="14471" source="Espacenet">
	<entities>
		<entity ref="Patent14471" type="Patent">
			<semanticIdentifier>brcris::4e43d0bc08c71655b88220252fe95913</semanticIdentifier>
			<semanticIdentifier>docdb::BR102016018199A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102016018199</semanticIdentifier>
			<semanticIdentifier>docdb::BR102016018199A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20161018199</semanticIdentifier>
			<semanticIdentifier>original::102016018199</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102016018199"/>
			<field name="identifier.lattes" value="4335833939769004"/>
			<field name="identifier.espacenet" value="102016018199"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="utilização de 7-cloroquinolino-1,2,3-triazoil carboxamidas como agentes terapêuticos antitumorais"/>
			<field name="title.lattes" value="UTILIZAÇÃO DE 7-CLOROQUINOLINO-1,2,3-TRIAZOIL CARBOXAMIDAS COMO AGENTES TERAPÊUTICOS ANTITUMORAIS"/>
			<field name="depositDate" value="2016-08-08"/>
			<field name="publicationDate" value="2018-03-06"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="BRUNA DE SOUZA GOLDANI"/>
			<field name="inventor" value="DIEGO DA SILVA ALVES"/>
			<field name="inventor" value="FABIANA KOMMLING SEIXAS"/>
			<field name="inventor" value="KARINE RECH BEGNINI"/>
			<field name="inventor" value="LIZIANE PEREIRA DA SILVA"/>
			<field name="inventor" value="LUCIELLI SAVEGNAGO"/>
			<field name="inventor" value="TIAGO VEIRAS COLLARES"/>
			<field name="inventor" value="WLADIMIR RIBEIRO DUARTE"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DE PELOTAS"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="C07D249/06AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="D"/>
				<field name="group" value="249"/>
				<field name="subgroup" value="06AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K31/4192AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="4192AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61P35/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="35"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="abstract.espacenet" value="a presente invenção refere-se à utilização de derivados sintéticos híbridos de 7-cloroquinolinas e 1,2,3-triazóis (7-cloroquinolino-1,2,3-triazoil carboxamidas) como agentes terapêuticos antitumorais. ainda, essa invenção refere-se ao uso isolado dos acima mencionados derivados sintéticos híbridos ou em combinação com fármacos quimioterápicos comercialmente disponíveis. a eficácia in vitro de três diferentes derivados sintéticos híbridos de 7-cloroquinolinas e 1,2,3-triazóis[1-(7-cloroquinolino-4-il)-5-metil-n-fenil-1h-1,2,3-triazoil-4-carboxamida; 1-(7-cloroquinolino-4-il)-n,5-difenil-1h-1,2,3-triazoil-4-carboxamida; e 1-(7-cloroquinolino-4-il)-n-fenil-5-(trifluorometil)-1h-1,2,3-triazoil-4-carboxamida] para utilização terapêutica em câncer de mama é demonstrada na presente invenção."/>
			<field name="originatesFrom" value="61970687"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102016018199"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102016018199"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102016018199"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20161018199"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102016018199"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person9993" type="Person">
			<semanticIdentifier>lattes::4335833939769004</semanticIdentifier>
			<field name="identifier.lattes" value="4335833939769004"/>
			<field name="name" value="Fabiana Kömmling Seixas"/>
		</entity>
		<entity ref="OrgUnit7844" type="OrgUnit">
			<semanticIdentifier>brcris::5aa56af182c84d54a22c21eb8549aed1</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE FEDERAL DE PELOTAS"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent14471" toEntityRef="Person9993" type="Inventor"/>
		<relation fromEntityRef="Patent14471" toEntityRef="OrgUnit7844" type="Applicant"/>
	</relations>
</entity-relation-data>
